DARK Daily: New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

PRESS RELEASE

THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
512-264-7103 o
512-264-0969 f

FOR IMMEDIATE RELEASE

Media Contact: Kristen Noonan
knoonan@darkreport.com

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

On Wednesday, March 24, 2021, Dark Daily hosted a free webinar, Emerging SARS-CoV-2 Mutations: Impact on Thermo Fisher Scientific Assay Performance, to discuss the important clinical implications (epidemiological, prognostic, and predictive) of these “variants of concern.”

Listen to this free webinar on demand, sponsored by Thermo Fisher Scientific, and learn the importance of early detection of these emerging SARS-CoV-2 variants and the steps your lab can take to confidently detect the COVID-19 virus with a very high degree of specificity and sensitivity, and identify the S-gene dropout.

This informative recorded webinar features the following panel of experts: Peter De Hoff, PhD, Project Scientist, Department of Reproductive Medicine, Sanford Consortium for Regenerative Medicine, UC San Diego; Manoj Gandhi, MD, PhD, Senior Medical Director, Thermo Fisher Scientific, San Francisco, CA; Karthik Gangavarapu, PhD Student, Andersen and Su Labs, Scripps Research Institute, La Jolla, CA; and Shashank Sathe, Bioinformatics Programmer, Yeo Lab, UC San Diego, San Diego, CA.

Tune into this 60-minute program and you will:

  • Get key insights into the novel SARS-CoV-2 strains including the UK variant (B.1.1.7) and the South African variant (B.1.351/501Y.V2) and the significant mutations associated with these variants
  • Understand automation and miniaturization of clinical SARS-CoV-2 RT-qPCR testing for population genomic surveillance
  • Learn how the TaqPath workflow addresses the S-gene dropout issue by detecting this unique variant
  • Discover how the mutations in these “variants of concern” are relevant to the different TaqPath COVID-19 assays
  • Hear how UCSD and Scripps are collaborating to deliver rapid and cost-effective genomic epidemiology to public health officials, and much more

Click here for more information and to stream this free webinar.

About The Dark Report

Established in 1995, The Dark Report is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists, and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces Dark Daily, as well as the renowned Executive War College on Laboratory and Pathology Management every spring.

-end-